A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts.

Overexpression of vascular endothelial growth factor (VEGF) is implicated in a number of diseases. It is therefore critical that mechanisms exist to strictly regulate VEGF expression. A hypoxia-responsive (HR) region of the VEGF promoter which binds the HIF-1 transcription factor is a target for many signals that up-regulate VEGF transcription. Repressors targeting the HIF-1 transcription factor have been identified but no repressors directly binding the HR promoter region had been reported. We now report a novel mechanism of repression of the VEGF HR region involving DNA binding. We find that single strand DNA-specific cold shock domain (CSD or Y-box) proteins repress the HR region via a binding site downstream of the HIF-1 site. The repressor site is functional in unstimulated, normoxic fibroblasts and represents a novel means to prevent expression of VEGF in the absence of appropriate stimuli. We characterized complexes forming on the VEGF repressor site and identified a previously unreported nuclear CSD protein complex containing dbpA. Nuclear dbpA appears to bind as a dimer and we determined a means by which nuclear CSD proteins may enter double strand DNA to bind to their single strand sites to bring about repression of the VEGF HR region.

[1]  J. Pouysségur,et al.  MAP Kinases and Hypoxia in the Control of VEGF Expression , 2004, Cancer and Metastasis Reviews.

[2]  D. Lovett,et al.  A Synergistic Interaction of Transcription Factors AP2 and YB-1 Regulates Gelatinase A Enhancer-dependent Transcription* , 1998, The Journal of Biological Chemistry.

[3]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[4]  M. Vadas,et al.  A sequence-specific single-strand DNA binding protein that contacts repressor sequences in the human GM-CSF promoter. , 1994, Nucleic acids research.

[5]  H. Hiai,et al.  Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress. , 2000, The American journal of pathology.

[6]  B. Shilo,et al.  Insulin induces transcription of target genes through the hypoxia‐inducible factor HIF‐1α/ARNT , 1998, The EMBO journal.

[7]  G. Goodall,et al.  Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. , 1999, Molecular biology of the cell.

[8]  J. Ting,et al.  The Transcriptional Regulatory Protein, YB-1, Promotes Single-stranded Regions in the DRA Promoter (*) , 1995, The Journal of Biological Chemistry.

[9]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[10]  K. Matsumoto,et al.  Gene regulation by Y-box proteins: coupling control of transcription and translation. , 1998, Trends in cell biology.

[11]  M. Burmeister,et al.  Cloning and Characterization of a Novel Transcriptional Repressor of the Nicotinic Acetylcholine Receptor -Subunit Gene (*) , 1996, The Journal of Biological Chemistry.

[12]  M. F. Shannon,et al.  Cold shock domain proteins repress transcription from the GM-CSF promoter. , 1996, Nucleic acids research.

[13]  H. Esumi,et al.  Identification of Hypoxia-inducible Factor 1 Ancillary Sequence and Its Function in Vascular Endothelial Growth Factor Gene Induction by Hypoxia and Nitric Oxide* , 2001, The Journal of Biological Chemistry.

[14]  Karl Matter,et al.  The tight junction protein ZO‐1 and an interacting transcription factor regulate ErbB‐2 expression , 2000, The EMBO journal.

[15]  R. Maki,et al.  Repression of major histocompatibility complex I-A beta gene expression by dbpA and dbpB (mYB-1) proteins , 1995, Molecular and cellular biology.

[16]  H. Uramoto,et al.  Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'-->5' exonuclease activity. , 2001, Nucleic acids research.

[17]  D. Lovett,et al.  YB-1 regulation of the human and rat gelatinase A genes via similar enhancer elements. , 1999, Journal of the American Society of Nephrology : JASN.

[18]  Rukmini Kolluri,et al.  A CT promoter element binding protein: definition of a double-strand and a novel single-strand DNA binding motif , 1992, Nucleic Acids Res..

[19]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[20]  G. Martiny-Baron,et al.  The pivotal role of VEGF in tumor angiogenesis: Molecular facts and therapeutic opportunities , 1998, Cancer and Metastasis Reviews.

[21]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[22]  D. Mukhopadhyay,et al.  Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner , 2000, Oncogene.

[23]  D. Shima,et al.  The Mouse Gene for Vascular Endothelial Growth Factor , 1996, The Journal of Biological Chemistry.

[24]  T. Ley,et al.  A human protein containing a "cold shock" domain binds specifically to H-DNA upstream from the human gamma-globin genes. , 1994, The Journal of biological chemistry.

[25]  J. Pouysségur,et al.  Signaling Angiogenesis via p42/p44 MAP Kinase Cascade , 2000, Annals of the New York Academy of Sciences.

[26]  M. F. Shannon,et al.  An Ordered Array of Cold Shock Domain Repressor Elements across Tumor Necrosis Factor-responsive Elements of the Granulocyte-Macrophage Colony-stimulating Factor Promoter* , 2000, The Journal of Biological Chemistry.

[27]  G. Semenza Expression of hypoxia-inducible factor 1: mechanisms and consequences. , 2000, Biochemical pharmacology.

[28]  R. Guntaka,et al.  Cloning of a novel Y-box homology protein (chkYB-1HP) cDNA lacking the cold-shock domain. , 1998, Biochimica et biophysica acta.

[29]  M. Shannon,et al.  The role of architectural transcription factors in cytokine gene transcription , 2001, Journal of leukocyte biology.

[30]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[31]  J. Gutkind,et al.  The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.

[32]  J. Pouysségur,et al.  Angiogenesis: how a tumor adapts to hypoxia. , 1999, Biochemical and biophysical research communications.

[33]  M. Marahiel,et al.  A superfamily of proteins that contain the cold-shock domain. , 1998, Trends in biochemical sciences.

[34]  H. Takano,et al.  Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression , 2000, Oncogene.

[35]  M. Makuuchi,et al.  Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. , 2000, Blood.

[36]  G. Semenza,et al.  HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression , 2001, Molecular and Cellular Biology.

[37]  S. Nordeen,et al.  Luciferase reporter gene vectors for analysis of promoters and enhancers. , 1988, BioTechniques.

[38]  Victor V Lobanenkov,et al.  Physical and Functional Interaction between Two Pluripotent Proteins, the Y-box DNA/RNA-binding Factor, YB-1, and the Multivalent Zinc Finger Factor, CTCF* , 2000, The Journal of Biological Chemistry.

[39]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[40]  M. F. Shannon,et al.  Signals for activation of the GM-CSF promoter and enhancer in T cells. , 1997, Critical reviews in immunology.

[41]  S. Mirkin,et al.  Triplex DNA structures. , 1995, Annual review of biochemistry.

[42]  M. Goldberg,et al.  Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*) , 1995, The Journal of Biological Chemistry.

[43]  J. Pouysségur,et al.  p42/p44 MAP Kinase Module Plays a Key Role in the Transcriptional Regulation of the Vascular Endothelial Growth Factor Gene in Fibroblasts* , 1998, The Journal of Biological Chemistry.

[44]  R. Xavier,et al.  Tumor Induction of VEGF Promoter Activity in Stromal Cells , 1998, Cell.

[45]  Y. Shi,et al.  Suppression of grp78 core promoter element-mediated stress induction by the dbpA and dbpB (YB-1) cold shock domain proteins , 1997, Molecular and cellular biology.

[46]  B. Dörken,et al.  Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression , 1997, Nature Medicine.

[47]  J. Norman,et al.  The Y-box Binding Protein YB-1 Suppresses Collagen α1(I) Gene Transcription via an Evolutionarily Conserved Regulatory Element in the Proximal Promoter* , 2001, The Journal of Biological Chemistry.

[48]  M. Vadas,et al.  Cold Shock Domain Factors Activate the Granulocyte-Macrophage Colony-stimulating Factor Promoter in Stimulated Jurkat T Cells* , 2001, The Journal of Biological Chemistry.

[49]  G. Semenza,et al.  HIF-1 and human disease: one highly involved factor. , 2000, Genes & development.

[50]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.